ClinicalTrials.gov
public full text
Public Domain
Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
The metabolic syndrome population is at high-risk of cardiovascular diseases and diabetes. How to effectively control the risk factors of this population is the key to primary prevention of cardiovascular diseases and diabetes in China. This study aims to explore the efficacy and safety of an intervention strategy with berberine that can effectively treat a variety of risk factors (hyperglycemia, dyslipidemia, hypertension).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus#836242
- Berberine and Altered Fasting Glucose#1127652
- Influência do polimorfismo 48867A>C (Asp358Ala) do gene do receptor da interleucina 6 na resposta a uma intervenção para modificação do estilo de vida em indivíduos com síndrome metabólica#946146
- Hypertension Registry of "Hypertension Prevention and Control Initiative in China"#841757
- Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides#1072464
Record · ID 885313
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive